Basic science in sexual medicine: Pathophysiology and new treatment options
Poster Session 84
-
Location:Room Berlin, North Hall (Level 1)
-
Chairs:
-
Aims and objectives of this session This session will provide the audience with latest news regarding pathophysiological mechanisms behind erectile dysfunction. Furthermore, evidence from in vitro and animal studies on possible new treatment options for erectile dysfunction, peyronies disease and hypogonadism will be presented. The audience will walk away with an idea of the future direction in the world of andrology.
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
Institutes: 1Hirslanden Klinik St. Anna, Dept. of Urology St. Anna, Luzern, Switzerland, 2University Hospital Bern, Dept. of Diagnostic and Interventional Neuroradiology, Bern, Switzerland, 3University Hospital Bern, Dept. of Urology, Bern, Switzerland, 4University Hospital Bern, Dept. of Diagnostic, Pediatric and Interventional Radiology, Bern, Switzerland, 5Luzerner Kantonsspital, Dept. of Urology, Luzern, Switzerland
Institutes: 1National Yang-Ming University Taipei Veterans General Hospital, Dept. of Urology and Physiology, Taipei, Taiwan, 2National Yang-Ming University, Dept. of Physiology, Taipei, Taiwan, 3National Yang-Ming University, Taipei Veterans General Hospital, Dept. of Pediatrics, Taipei, Taiwan
Institutes: 1Anglia Ruskin University, Faculty of Medical Science, Chelmsford, United Kingdom, 2Cranfield University, Cranfield Health, Bedfordshire, United Kingdom, 3University College London Hospital, Dept. of Andrology, London, United Kingdom
Institutes: 1Azienda Ospedaliero Universitaria di Trieste, Dept. of Urology, Trieste, Italy, 2University of Udine, Dept. of Medical and Biological Sciences, Udine, Italy, 3CRO Aviano National Cancer Institute, Experimental and Clinical Pharmacology Unit, Aviano, Italy, 4University Hospital Santa Maria Della Misericordia, University of Udine, Udine, Italy, 5University Hospital Santa Maria Della Misericordia, Dept. of Dermatology, Udine, Italy
Institutes: 1Hospital Universitario Puerta de Hierro-Majadahonda, Dept. of Urology, Majadahonda, Spain, 2Hospital Universitario Ramón Y Cajal, IRYCIS, Madrid, Spain
Institutes: 1Cardinal Tien Hospital, Dept. of Urology, New Taipei City, Taiwan, 2Fu-Jen Catholic University, Dept. of Urology, New Taipei City, Taiwan
Institutes: 1Université De Versailles Saint-Quentin-En-Yvelines, AP-HP Raymond Poincaré Hospital-Dept. of Neurological Rehabilitation, Garches, France, 2Université De Versailles Saint-Quentin-En-Yvelines, Pelvipharm, Montigny-Le-Bretonneux, France
Institutes: 1Marmara University School of Medicine, Dept. of Urology, Istanbul, Turkey, 2Istanbul Bilim University, Istanbul Florence Nightingale Hospital, Dept. of Urology, Istanbul, Turkey, 3Marmara University, School of Medicine, Dept. of Radiation Oncology, Istanbul, Turkey, 4Cumhuriyet University, School of Pharmacy, Dept. of Biochemistry, Sivas, Turkey, 5Marmara University, School of Pharmacy, Dept. of Pharmacology, Istanbul, Turkey, 6Marmara University, School of Medicine, Dept. of Histology & Embryology, Istanbul, Turkey
Institutes: 1Hospital Universitario Puerta de Hierro-Majadahonda, Dept. of Urology, Majadahonda, Spain, 2Hospital Universitario Ramón Y Cajal, IRYCIS, Madrid, Spain, 3Hospital Universitario Ramón Y Cajal, Dept. of Urology, Madrid, Spain, 4Hospital Universitario De Getafe, Dept. of Geriatrics, Madrid, Spain